GSK set­tles an­oth­er heart­burn drug Zan­tac can­cer case in Cal­i­for­nia, does­n't ad­mit li­a­bil­i­ty

GSK set­tled a Zan­tac can­cer case in Cal­i­for­nia state court, this time pay­ing out a con­fi­den­tial set­tle­ment and avoid­ing a Nov. 13 start date for the tri­al, the com­pa­ny said Wednes­day.

GSK al­so set­tled three re­main­ing bell­wether breast can­cer cas­es in Cal­i­for­nia, the on­ly state the com­pa­ny has set­tled in. It’s still in­volved in 3,100 cas­es in Cal­i­for­nia state court. There are al­so clus­ters of lit­i­ga­tion in oth­er states like Flori­da, though the largest num­ber of cas­es is in Delaware, with over 73,000 of them on­go­ing, ac­cord­ing to a GSK rep­re­sen­ta­tive.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER